zepbound a glp 1 GLP1 Drug Use For Weight Loss Has Soared Costing Billions Is Zepbound a Semaglutide GLP-1?
Description
33 receiving placebo

Cardiovasc Diabetol 19(1):156 International Diabetes Federation (2022) Brussels: International Diabetes Federation
&srotate=0)
Consult your OB-GYN and pediatrician to evaluate your individual risk-benefit profile before starting treatment

Elsaid MI, Li N, Firkins SA, Rustgi VK, Paskett ED, Acharya C, Reddy KR, Chiang CW, Mumtaz K
4 While MASLD is an umbrella term for hepatic steatosis (fat in the liver) in association with at least 1 metabolic risk factor (overweight or obesity, type 2 diabetes, dyslipidemia, hypertension), in MASH there is also hepatic inflammation and hepatocyte ballooning, with a high risk of progression and fibrosis
